Actively Recruiting
Maternal Intake of Eggs and Infant Neurodevelopment
Led by University of Kansas Medical Center · Updated on 2026-05-13
100
Participants Needed
1
Research Sites
126 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The fetal brain requires DHA, choline, lutein, and zeaxanthin (L/Z) for development, dependent on maternal intake during pregnancy. However, many pregnant women do not meet daily requirements through diet or prenatal vitamins. Egg yolks are rich in choline, and women who consume eggs daily are more likely to meet the adequate intake of 450 mg/day. A recent study by Christifano et al. found that maternal egg and neuroprotective nutrient intake predicted neurodevelopment at 32 and 36 weeks of gestation. This study aims to determine if fetal neurodevelopment is enhanced among women who consume a prenatal diet emphasizing egg consumption (EGG) versus a healthy prenatal diet education control group (HPD). Women between 12-20 weeks' gestation will be randomized into EGG and HPD groups. The EGG group will receive education on the importance of prenatal choline and egg consumption and be encouraged to consume 10-14 eggs per week. The HPD group will receive education on a healthy prenatal diet. Both groups will be encouraged to take a DHA supplement, and dietary intake of choline, L/Z, and DHA will be collected. Fetal heart rate variability will be measured at 36 weeks gestation and infant EEGs will be conducted postnatally to examine brain function. Increasing prenatal egg consumption is both economical and feasible to boost prenatal choline intake, promote offspring neurodevelopment, and guide prenatal dietary recommendations.
CONDITIONS
Official Title
Maternal Intake of Eggs and Infant Neurodevelopment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant females 18 years or older
- Between 12 and 20 weeks pregnant at enrollment
- No serious illnesses that could affect study results
- Eating 3 eggs or less per week at enrollment and willing to increase egg intake
- Pregnant with only one baby
- Have access to telephone and text messaging
You will not qualify if you...
- Under 18 years old at enrollment
- Less than 12 weeks or more than 20 weeks pregnant at enrollment
- Any serious illness likely to affect study results
- Eating more than 3 eggs per week at enrollment
- Unable or unwilling to eat eggs until delivery or egg allergy
- Expecting twins or more
- No access to telephone or text messaging
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The University of Kansas Medical Center
Kansas City, Kansas, United States, 66160
Actively Recruiting
Research Team
N
Nicole Mathis, MS
CONTACT
L
Lara Bennett, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here